Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor Antagonists

被引:24
|
作者
Xia, Lizi [1 ]
Burger, Wessel A. C. [1 ]
van Veldhoven, Jacobus P. D. [1 ]
Kuiper, Boaz J. [1 ]
van Duijl, Tirsa T. [1 ]
Lenselink, Eelke B. [1 ]
Paasman, Ellen [1 ]
Heitman, Laura H. [1 ]
IJzerman, Adriaan P. [1 ]
机构
[1] Leiden Univ, Leiden Acad Ctr Drug Res, Div Med Chem, NL-2300 RA Leiden, Netherlands
关键词
PROTEIN-COUPLED RECEPTOR; TARGET RESIDENCE TIME; MEDICINAL CHEMISTRY; CLICK CHEMISTRY; LIGAND; BINDING; RADIOLIGAND; THERMODYNAMICS; GPCRDB;
D O I
10.1021/acs.jmedchem.7b00950
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We expanded on a series of pyrido[2,1-f]purine-2,4-clione derivatives as human adenosine A(3) receptor (hA(3)R) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hA(3)R antagonists with very short residence time (RT) at the receptor (2.2 min for 5) and much longer RTs (e.g., 376 min for 27 or 391 min for 31). Two representative antagonists (5 and 27) were tested in [S-35]GTP gamma S binding assays, and their RTs appeared correlated to their (in)surmountable antagonism. From a k(on)-k(off)-K-D kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hA(3)R antagonists. Additionally, we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compounds' binding kinetics. Knowledge of target binding kinetics appears useful for developing and triaging new hA(3)R antagonists in the early phase of drug discovery.
引用
收藏
页码:7555 / 7568
页数:14
相关论文
共 47 条
  • [31] 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: Design, synthesis, structure-affinity and structure-selectivity relationships
    Stefanachi, Angela
    Nicolotti, Orazio
    Leonetti, Francesco
    Cellamare, Saverio
    Campagna, Francesco
    Isabel Loza, Maria
    Manuel Brea, Jose
    Mazza, Fernando
    Gavuzzo, Enrico
    Carotti, Angelo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (22) : 9780 - 9789
  • [32] Structure-Activity Relationships of Truncated C2- or C8-Substituted Adenosine Derivatives as Dual Acting A2A and A3 Adenosine Receptor Ligands
    Hou, Xiyan
    Majik, Mahesh S.
    Kim, Kyunglim
    Pyee, Yuna
    Lee, Yoonji
    Alexander, Varughese
    Chung, Hwa-Jin
    Lee, Hyuk Woo
    Chandra, Girish
    Lee, Jin Hee
    Park, Seul-gi
    Choi, Won Jun
    Kim, Hea Ok
    Phan, Khai
    Gao, Zhan-Guo
    Jacobson, Kenneth A.
    Choi, Sun
    Lee, Sang Kook
    Jeong, Lak Shin
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 342 - 356
  • [33] Antidepressant-like activity and safety profile evaluation of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione derivatives as 5-HT1Areceptor partial agonists
    Partyka, Anna
    Zagorska, Agnieszka
    Kotanska, Magdalena
    Walczak, Maria
    Jastrzebska-Wiesek, Magdalena
    Knutelska, Joanna
    Bednarski, Marek
    Gluch-Lutwin, Monika
    Mordyl, Barbara
    Janiszewska, Paulina
    Wesolowska, Anna
    PLOS ONE, 2020, 15 (08):
  • [34] Structure-activity relationships of 2-chloro-N6-substituted-4′-thioadenosine-5′-N,N-dialkyluronamides as human A3 adenosine receptor antagonists
    Jeong, Lak Shin
    Lee, Hyuk Woo
    Kim, Hea Ok
    Tosh, Dilip K.
    Pal, Shantanu
    Choi, Won Jun
    Gao, Zhan-Guo
    Patel, Amit R.
    Williams, Wanda
    Jacobson, Kenneth A.
    Kim, Hee-Doo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (05) : 1612 - 1616
  • [35] Synthesis and structure-activity relationships of a new set of 2-arylpyrazolo[3,4-c] quinoline derivatives as adenosine receptor antagonists
    Colotta, V
    Catarzi, D
    Varano, F
    Cecchi, L
    Filacchioni, G
    Martini, C
    Trincavelli, L
    Lucacchini, A
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (16) : 3118 - 3124
  • [36] Characteristics of metabolic stability and the cell permeability of 2-pyrimidinyl-piperazinyl-alkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione with antidepressant- and anxiolytic-like activities
    Zagorska, Agnieszka
    Partyka, Anna
    Bucki, Adam
    Kolaczkowski, Marcin
    Jastrzebska-Wiesek, Magdalena
    Czopek, Anna
    Siwek, Agata
    Gluch-Lutwin, Monika
    Bednarski, Marek
    Bajda, Marek
    Jonczyk, Jakub
    Piska, Kamil
    Koczurkiewicz, Paulina
    Wesolowska, Anna
    Pawlowski, Maciej
    CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 93 (04) : 511 - 521
  • [37] Synthesis and structure-activity relationships of 4-cycloalkylamino-1,2,4-triazolo[4 3-a]quinoxalin-1-one derivatives as A1 and A3 adenosine receptor antagonists
    Colotta, V
    Catarzi, D
    Varano, F
    Filacchioni, G
    Martini, C
    Trincavelli, L
    Lucacchini, A
    ARCHIV DER PHARMAZIE, 2004, 337 (01) : 35 - 41
  • [38] Substituted 1, 3, 5-triazine derivatives as adenosine A2A receptor antagonists: Synthesis, structure-activity relationships and molecular modelling studies
    Singh, Udaya
    Bhat, Hans
    MOVEMENT DISORDERS, 2014, 29 : S62 - S62
  • [39] Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-uronamides as human A3 adenosine receptor agonists
    Jeong, LS
    Lee, HW
    Gao, ZG
    Kenneth, AJ
    Shin, DH
    Lee, JA
    Kim, AY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2548 - U2548
  • [40] 2-phenylimidazo[2,1-i]purin-5-ones:: Structure-activity relationships and characterization of potent and selective inverse agonists at human A3 adenosine receptors
    Ozola, V
    Thorand, M
    Diekmann, M
    Qurishi, R
    Schumacher, B
    Jacobson, KA
    Müller, CE
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (03) : 347 - 356